106 filings
Page 3 of 6
CORRESP
94vn1pvl2za9h
7 Nov 23
Correspondence with SEC
12:00am
S-8
3we aukewq
2 Nov 23
Registration of securities for employees
4:05pm
8-K
nz8nok
24 Oct 23
Submission of Matters to a Vote of Security Holders
4:15pm
DEFA14A
fl7rqp lc
29 Sep 23
Additional proxy soliciting materials
4:05pm
8-K
8eq6j13x
25 Sep 23
Expects to launch and complete a Phase 1 trial in Q4 2023
4:15pm
8-K
m6x 3xh6i8r
12 Sep 23
Regulation FD Disclosure
8:30am
DEFA14A
kkavh0bume3hq
30 Aug 23
Additional proxy soliciting materials
5:22pm
PRE 14A
katsb wtb
18 Aug 23
Preliminary proxy
5:15pm
8-K
i42b z1lvc
17 Jul 23
Changes in Registrant's Certifying Accountant
4:15pm
8-K
86qxbjfl
11 Jul 23
Entry into a Material Definitive Agreement
5:25pm
8-K
8wolq
20 Jun 23
Changes in Registrant's Certifying Accountant
4:54pm
8-K
lqbxxdbfd
16 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
10-K/A
hm9gd65230z6db
19 May 23
Annual report (amended)
7:21pm
8-K
fqpsyu6
19 May 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
7:16pm
NT 10-Q
zx85dxloj3jzmd
16 May 23
Notice of late quarterly filing
4:15pm
8-K
cazl8n3qyimx fyu8lv
15 May 23
Hillstream BioPharma Strengthens its Board of Directors with Appointment of Kelly Anderson
12:00am